Document ID: chunk:federal_register_of_legislation:F2022C00893:reg:9:p3
Version: federal_register_of_legislation:F2022C00893
Segment Type: reg
Provision Reference: reg 9 (pt 3/6)
Character Range: 10564–13615

days before the clinical onset of tinnitus;
(22)      having temporomandibular disorder at the time of the clinical onset of tinnitus;
(23)      having trigeminal neuralgia at the time of the clinical onset of tinnitus;
(24)      having migraine or tension-type headache before the clinical onset of tinnitus;
(25)      having Meniere's disease or delayed endolymphatic hydrops at the time of the clinical onset of tinnitus;
(26)      having:
(a)          an episode of otitic barotrauma involving the affected ear; or
(b)          cerebral arterial gas embolism; or
(c)          decompression sickness;
         within the 30 days before the clinical onset of tinnitus;
Note: Otitic barotrauma is also known as otic barotrauma.
(27)      having acoustic shock at the time of the clinical onset of tinnitus;
            Note: acoustic shock is defined in the Schedule 1 - Dictionary.
(28)      having a bacterial infection from the specified list of bacterial infections within the 30 days before the clinical onset of tinnitus;
            Note: specified list of bacterial infections is defined in the Schedule 1 - Dictionary.
(29)      having a viral infection from the specified list of viral infections within the 30 days before the clinical onset of tinnitus;
            Note: specified list of viral infections is defined in the Schedule 1 - Dictionary.
(30)      having meningitis or encephalitis within the one year before the clinical onset of tinnitus;
(31)      having neurosyphilis before the clinical onset of tinnitus;
(32)      having tuberculosis involving the nasopharynx, meninges, temporal bone, middle ear or inner ear of the affected side before the clinical onset of tinnitus;
(33)      having typhoid fever within the 30 days before the clinical onset of tinnitus;
(34)      undergoing a course of therapeutic radiation for cancer, where the auditory apparatus was in the field of radiation, before the clinical onset of tinnitus;
(35)      having:
(a)          a cobalt-containing metal-on-metal hip prosthesis; or
(b)          a serum cobalt concentration of at least 200 micrograms per litre;
for at least the four weeks before the clinical onset of tinnitus;
(36)      having vitamin B1 (thiamine) or vitamin B12 (cobalamin) deficiency at the time of the clinical onset of tinnitus;
(37)      having carbon monoxide poisoning within the 48 hours before the clinical onset of tinnitus;
(38)      having hypothyroidism for at least the three months before the clinical onset of tinnitus;
(39)      having a clinically significant depressive disorder or a clinically significant anxiety disorder at the time of the clinical onset of tinnitus;
            Note: clinically significant is defined in the Schedule 1 - Dictionary.
(40)      being exposed to a peak sound pressure level at the tympanic membrane of at least 140 dB(C) before the clinical worsening of tinnitus;
            Note: dB(C) is defined in the Schedule 1 - Dictionary.
(41)      being exposed to a sound pressure level at the tympanic membrane of at least